Eagle Bay Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9
| Closed | -$1.38K | – | 215 |
|
|
2024
Q4 | $1.38K | Sell |
9
-17
| -65% | -$2.6K | ﹤0.01% | 922 |
|
|
2024
Q3 | $5.04K | Hold |
26
| – | – | ﹤0.01% | 1007 |
|
|
2024
Q2 | $6.03K | Hold |
26
| – | – | ﹤0.01% | 666 |
|
|
2024
Q1 | $5.61K | Buy |
26
+17
| +189% | +$3.67K | ﹤0.01% | 697 |
|
|
2023
Q4 | $2.33K | Hold |
9
| – | – | ﹤0.01% | 725 |
|
|
2023
Q3 | $2.31K | Hold |
9
| – | – | ﹤0.01% | 745 |
|
|
2023
Q2 | $2.56K | Sell |
9
-152
| -94% | -$43.3K | ﹤0.01% | 734 |
|
|
2023
Q1 | $44.8K | Hold |
161
| – | – | 0.02% | 403 |
|
|
2022
Q4 | $44.6K | Sell |
161
-31
| -16% | -$8.58K | 0.03% | 398 |
|
|
2022
Q3 | $51K | Sell |
192
-20
| -9% | -$5.31K | 0.03% | 327 |
|
|
2022
Q2 | $43.2K | Buy |
+212
| New | +$43.2K | 0.03% | 392 |
|
|
2022
Q1 | – | Sell |
-223
| Closed | -$54K | – | 368 |
|
|
2021
Q4 | $54K | Sell |
223
-131
| -37% | -$31.7K | 0.03% | 340 |
|
|
2021
Q3 | $100K | Buy |
354
+177
| +100% | +$50K | 0.06% | 229 |
|
|
2021
Q2 | $62K | Buy |
+177
| New | +$62K | 0.05% | 268 |
|